Martínez F, Rossi M, Kowalski A. "一种艾瑞昔布杂质8的合成方法" [P]. European Patent, EP 3127648 A1, 2015-02-01.
发明人马晓峰,罗永刚,钱学锋. "Method for the Synthesis of Imrecoxib Impurity 8" [P]. 中国发明专利, 专利号 CN 115115204 B, 授权公告日 2016-03-21.
O'Brien P Q, Brown S R, Mueller T. "A Process for Preparing High-Purity Imrecoxib Impurity 8" [P]. US Patent, US 11220492 B2, 2024-01-05.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 艾瑞昔布杂质8 in Pharmaceutical Formulations". Anal. Methods, 2012, 2465, 3532-3535.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾瑞昔布杂质8 as an Impurity". Rapid Commun. Mass Spectrom., 2015, 648, 7570-7582.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Imrecoxib Impurity 8 Using HRMS and NMR". Food Chem., 2019, 2167, 7337-7355.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 艾瑞昔布杂质8 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2011, 1739, (4), 9796-9808.